Quick Answer
Gossamer Bio, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $48.47 million for the year ending 2025.
- Gossamer Bio, Inc. showed a decrease of -57.7% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Gossamer Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $48.47 million | Fiscal year 2024: $114.70 million | Fiscal year 2023: $0.00 | Fiscal year 2022: $0.00.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: